BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31445765)

  • 1. Combination of Glomerular C4d and Morphologic Glomerular Lesions as a Possible Indicator in the Diagnosis of Acute or Chronic Active Antibody-Mediated Rejection.
    Lee YJ; Lee JH; Jung CW; Gwon JG; Ko SY; Lee J; Jo SK; Cho WY; Kim MG
    Transplant Proc; 2019 Oct; 51(8):2660-2666. PubMed ID: 31445765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Capillary C4d and Kidney Allograft Outcome in Relation to Morphologic Lesions Suggestive of Antibody-Mediated Rejection.
    Kikić Ž; Kainz A; Kozakowski N; Oberbauer R; Regele H; Bond G; Böhmig GA
    Clin J Am Soc Nephrol; 2015 Aug; 10(8):1435-43. PubMed ID: 26071493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and pathological analyses of transplant glomerulopathy cases.
    Shimizu T; Ishida H; Toki D; Nozaki T; Omoto K; Tanabe K; Honda K; Koike J
    Nephrology (Carlton); 2014 Jun; 19 Suppl 3():21-6. PubMed ID: 24842817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infiltrating cell types in transplant glomerulitis: relationship to peritubular capillary C4d deposition.
    Magil AB
    Am J Kidney Dis; 2005 Jun; 45(6):1084-9. PubMed ID: 15957138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glomerular C4d deposits can mark structural capillary wall remodelling in thrombotic microangiopathy and transplant glomerulopathy: C4d beyond active antibody-mediated injury: a retrospective study.
    Gasim AH; Chua JS; Wolterbeek R; Schmitz J; Weimer E; Singh HK; Nickeleit V
    Transpl Int; 2017 May; 30(5):519-532. PubMed ID: 28207978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Outcome of C4d Staining With Tubulointerstitial Inflammation in Blood Group-incompatible Kidney Transplantation.
    Couzi L; Perera R; Manook M; Barnett AN; Shaw O; Kessaris N; Marks SD; Dorling A; Mamode N
    Transplantation; 2015 Jul; 99(7):1487-94. PubMed ID: 26151608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Banff 2013 update: Pearls and pitfalls in transplant renal pathology.
    Hara S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():2-8. PubMed ID: 26031578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunologic risk factors and glomerular C4d deposits in chronic transplant glomerulopathy.
    Sijpkens YW; Joosten SA; Wong MC; Dekker FW; Benediktsson H; Bajema IM; Bruijn JA; Paul LC
    Kidney Int; 2004 Jun; 65(6):2409-18. PubMed ID: 15149354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical and genomic significance of donor-specific antibody-positive/C4d-negative and donor-specific antibody-negative/C4d-negative transplant glomerulopathy.
    Hayde N; Bao Y; Pullman J; Ye B; Calder RB; Chung M; Schwartz D; Lubetzky M; Ajaimy M; de Boccardo G; Akalin E
    Clin J Am Soc Nephrol; 2013 Dec; 8(12):2141-8. PubMed ID: 24030736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capillary deposition of complement split product C4d in renal allografts is associated with basement membrane injury in peritubular and glomerular capillaries: a contribution of humoral immunity to chronic allograft rejection.
    Regele H; Böhmig GA; Habicht A; Gollowitzer D; Schillinger M; Rockenschaub S; Watschinger B; Kerjaschki D; Exner M
    J Am Soc Nephrol; 2002 Sep; 13(9):2371-80. PubMed ID: 12191982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.
    Meehan SM; Kremer J; Ali FN; Curley J; Marino S; Chang A; Kadambi PV
    Clin J Am Soc Nephrol; 2011 Feb; 6(2):395-403. PubMed ID: 20966124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolving criteria for the diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Nephrol Hypertens; 2018 May; 27(3):137-143. PubMed ID: 29300203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
    Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.
    Mauiyyedi S; Crespo M; Collins AB; Schneeberger EE; Pascual MA; Saidman SL; Tolkoff-Rubin NE; Williams WW; Delmonico FL; Cosimi AB; Colvin RB
    J Am Soc Nephrol; 2002 Mar; 13(3):779-787. PubMed ID: 11856785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glomerulitis and endothelial cell enlargement in C4d+ and C4d- acute rejections of renal transplant patients.
    Aiello FB; Furian L; Della Barbera M; Marino S; Seveso M; Cardillo M; Pierobon ES; Cozzi E; Rigotti P; Valente M
    Hum Pathol; 2012 Dec; 43(12):2157-66. PubMed ID: 22647352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Banff Component Scoring-based Histologic Assessment of Bortezomib-based Antibody-mediated Rejection Therapy.
    Sadaka B; Ejaz NS; Shields AR; Cardi MA; Wadih G; Witte D; Abu Jawdeh BG; Alloway RR; Woodle ES
    Transplantation; 2015 Aug; 99(8):1691-9. PubMed ID: 25803498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of C4d deposition in antibody-mediated rejection.
    Takeda A; Otsuka Y; Horike K; Inaguma D; Hiramitsu T; Yamamoto T; Nanmoku K; Goto N; Watarai Y; Uchida K; Morozumi K; Kobayashi T
    Clin Transplant; 2012 Jul; 26 Suppl 24():43-8. PubMed ID: 22747475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An updated Banff schema for diagnosis of antibody-mediated rejection in renal allografts.
    Haas M
    Curr Opin Organ Transplant; 2014 Jun; 19(3):315-22. PubMed ID: 24811440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C4d deposition is associated with immune cells infiltrating in kidney allograft glomerulitis and peritubular capillaritis.
    Jin J; Li YW; He Q
    Ren Fail; 2015 Jun; 37(5):791-7. PubMed ID: 25869053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in pathologic features and graft outcomes in antibody-mediated rejection of renal allografts due to persistent/recurrent versus de novo donor-specific antibodies.
    Haas M; Mirocha J; Reinsmoen NL; Vo AA; Choi J; Kahwaji JM; Peng A; Villicana R; Jordan SC
    Kidney Int; 2017 Mar; 91(3):729-737. PubMed ID: 28104301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.